BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, Sharma M, Sachdev M, Grover AK, Surve A, Budharapu A, Ramadhin AK, Tripathi AK, Gupta A, Bhargava A, Sahu A, Khairnar A, Kochar A, Madhavani A, Shrivastava AK, Desai AK, Paul A, Ayyar A, Bhatnagar A, Singhal A, Nikose AS, Bhargava A, Tenagi AL, Kamble A, Nariani A, Patel B, Kashyap B, Dhawan B, Vohra B, Mandke C, Thrishulamurthy C, Sambare C, Sarkar D, Mankad DS, Maheshwari D, Lalwani D, Kanani D, Patel D, Manjandavida FP, Godhani F, Agarwal GA, Ravulaparthi G, Shilpa GV, Deshpande G, Thakkar H, Shah H, Ojha HR, Jani H, Gontia J, Mishrikotkar JP, Likhari K, Prajapati K, Porwal K, Koka K, Dharawat KS, Ramamurthy LB, Bhattacharyya M, Saini M, Christy MC, Das M, Hada M, Panchal M, Pandharpurkar M, Ali MO, Porwal M, Gangashetappa N, Mehrotra N, Bijlani N, Gajendragadkar N, Nagarkar NM, Modi P, Rewri P, Sao P, Patil PS, Giri P, Kapadia P, Yadav P, Bhagat P, Parekh R, Dyaberi R, Chauhan RS, Kaur R, Duvesh RK, Murthy R, Dandu RV, Kathiara R, Beri R, Pandit R, Rani RH, Gupta R, Pherwani R, Sapkal R, Mehta R, Tadepalli S, Fatima S, Karmarkar S, Patil SS, Shah S, Shah S, Shah S, Dubey S, Gandhi S, Kanakpur S, Mohan S, Bhomaj S, Kerkar S, Jariwala S, Sahu S, Tara S, Maru SK, Jhavar S, Sharma S, Gupta S, Kumari S, Das S, Menon S, Burkule S, Nisar SP, Kaliaperumal S, Rao S, Pakrasi S, Rathod S, Biradar SG, Kumar S, Dutt S, Bansal S, Ravani SA, Lohiya S, Ali Rizvi SW, Gokhale T, Lahane TP, Vukkadala T, Grover T, Bhesaniya T, Chawla U, Singh U, Une VL, Nandedkar V, Subramaniam V, Eswaran V, Chaudhry VN, Rangarajan V, Dehane V, Sahasrabudhe VM, Sowjanya Y, Tupkary Y, Phadke Y; members of the Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC) Study Group. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol 2021;69:1670-92. [PMID: 34156034 DOI: 10.4103/ijo.IJO_1565_21] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Panta P, Stone N. COVID-associated mucormycosis (CAM) in India is a multidimensional problem. Br J Oral Maxillofac Surg 2021:S0266-4356(21)00334-X. [PMID: 34728106 DOI: 10.1016/j.bjoms.2021.08.008] [Reference Citation Analysis]
2 Dubey S, Mukherjee D, Sarkar P, Mukhopadhyay P, Barman D, Bandopadhyay M, Pandit A, Sengupta A, Das S, Ghosh S, Adhikari S, Biswas PS, Pal P, Roy H, Patra N, Das A, Sinha P, Mondal MK, Shrivastava SR, Bhattacharya K, Mukhopadhyay M, Ahmed K, Halder TK, Saha M, Ahmed K, Maity S, Mandal A, Chatterjee D, Saha S, Chunakar A, Saha A, Ray BK. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum. Diabetes Metab Syndr 2021;15:102267. [PMID: 34509790 DOI: 10.1016/j.dsx.2021.102267] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nair AG, Dave TV. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review. Orbit 2021;:1-12. [PMID: 34720026 DOI: 10.1080/01676830.2021.1990351] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Narayanan S, Chua JV, Baddley JW. COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease. Clin Infect Dis 2021:ciab726. [PMID: 34420052 DOI: 10.1093/cid/ciab726] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
5 Padma Srivastava MV, Vishnu VY, Pandit AK. Mucormycosis Epidemic and Stroke in India During the COVID-19 Pandemic. Stroke 2021;52:e622-3. [PMID: 34525840 DOI: 10.1161/STROKEAHA.121.036626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Sarkar S, Gokhale T, Farnaz Y, Deb AK. Smartphone-assisted retinal evaluation in COVID-19 admitted patients. Indian J Ophthalmol 2021;69:2884-5. [PMID: 34571665 DOI: 10.4103/ijo.IJO_2043_21] [Reference Citation Analysis]
7 Kumar H M, Sharma P, Rudramurthy SM, Sehgal IS, Prasad KT, Pannu AK, Das R, Panda NK, Sharma N, Chakrabarti A, Agarwal R, Muthu V. Serum iron indices in COVID-19-associated mucormycosis: A case-control study. Mycoses 2021. [PMID: 34743358 DOI: 10.1111/myc.13391] [Reference Citation Analysis]
8 Arora R, Goel R, Khanam S, Kumar S, Shah S, Singh S, Chhabra M, Meher R, Khurana N, Sagar T, Kumar S, Garg S, Kumar J, Saxena S, Pant R. Rhino-Orbito-Cerebral-Mucormycosis During the COVID-19 Second Wave in 2021 - A Preliminary Report from a Single Hospital. Clin Ophthalmol 2021;15:3505-14. [PMID: 34429582 DOI: 10.2147/OPTH.S324977] [Reference Citation Analysis]
9 Wiederhold NP. Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance. Clinical Chemistry 2022;68:83-90. [DOI: 10.1093/clinchem/hvab217] [Reference Citation Analysis]
10 Aranjani JM, Manuel A, Abdul Razack HI, Mathew ST. COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India. PLoS Negl Trop Dis 2021;15:e0009921. [PMID: 34793455 DOI: 10.1371/journal.pntd.0009921] [Reference Citation Analysis]
11 Sahu AK, Mathew R, Bhat R, Malhotra C, Nayer J, Aggarwal P, Galwankar S. Steroids use in non-oxygen requiring COVID-19 patients: a systematic review and meta-analysis. QJM 2021;114:455-63. [PMID: 34347106 DOI: 10.1093/qjmed/hcab212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ambereen A, Rahman SA, Rehman S, Zaidi K, Arif SH. Mandibular mucormycosis following SARS-CoV-2 infection - A case report and review of literature. Clin Infect Pract 2021;12:100099. [PMID: 34568807 DOI: 10.1016/j.clinpr.2021.100099] [Reference Citation Analysis]
13 Sarda R, Swain S, Ray A, Wig N. COVID-19 associated Mucormycosis and evolving evidence. QJM 2021:hcab191. [PMID: 34264346 DOI: 10.1093/qjmed/hcab191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Choksi T, Agrawal A, Date P, Rathod D, Gharat A, Ingole A, Chaudhari B, Pawar N. Cumulative Mortality and Factors Associated With Outcomes of Mucormycosis After COVID-19 at a Multispecialty Tertiary Care Center in India. JAMA Ophthalmol 2021. [PMID: 34882192 DOI: 10.1001/jamaophthalmol.2021.5201] [Reference Citation Analysis]
15 Kumar M, Sarma DK, Shubham S, Kumawat M, Verma V, Singh B, Nagpal R, Tiwari RR. Mucormycosis in COVID-19 pandemic: Risk factors and linkages. Curr Res Microb Sci 2021;2:100057. [PMID: 34396355 DOI: 10.1016/j.crmicr.2021.100057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Bhat V, S A, Thomas A, Kanavi JV, Thomas A. Intestinal Perforation Secondary to Mucormycosis Associated With Puerperal Sepsis. Cureus 2021;13:e17428. [PMID: 34589337 DOI: 10.7759/cureus.17428] [Reference Citation Analysis]
17 Sarkar S, Gokhale T, Kaliaperumal S, Singh R, Begam RB, Deb AK. Exudative retinal detachment in COVID-19 - associated rhino-orbital mucormycosis - A rare clinical finding. Indian J Ophthalmol 2021;69:2535-7. [PMID: 34427262 DOI: 10.4103/ijo.IJO_1729_21] [Reference Citation Analysis]
18 Garg RK, Malhotra HS, Pandey S. Neurological infections in 2021: a spotlight on India. Lancet Neurol 2022;21:17-8. [PMID: 34942126 DOI: 10.1016/S1474-4422(21)00415-4] [Reference Citation Analysis]
19 Al-Tawfiq JA, Alhumaid S, Alshukairi AN, Temsah MH, Barry M, Al Mutair A, Rabaan AA, Al-Omari A, Tirupathi R, AlQahtani M, AlBahrani S, Dhama K. COVID-19 and mucormycosis superinfection: the perfect storm. Infection 2021. [PMID: 34302291 DOI: 10.1007/s15010-021-01670-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Banerjee I, Robinson J, Asim M, Sathian B, Banerjee I. Mucormycosis and COVID-19 an epidemic in a pandemic? Nepal J Epidemiol 2021;11:1034-9. [PMID: 34290893 DOI: 10.3126/nje.v11i2.37342] [Reference Citation Analysis]
21 Crone CG, Helweg-Larsen J, Steensen M, Arendrup MC, Helleberg M. Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap. J Mycol Med 2021;32:101228. [PMID: 34826672 DOI: 10.1016/j.mycmed.2021.101228] [Reference Citation Analysis]
22 Badali H, Cañete-Gibas C, McCarthy D, Patterson H, Sanders C, David MP, Mele J, Fan H, Wiederhold NP. Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States. J Clin Microbiol 2021;59:e0123021. [PMID: 34232068 DOI: 10.1128/JCM.01230-21] [Reference Citation Analysis]
23 Bhat VK, Bongale KR, Basti SP, Gadag RP, Kizhakkilottu N, Sebastian E, Gopalegowda MK, Thammaiah P. Risk factors for palatal and orbital involvement in mucormycosis epidemic–Report of a center in India. American Journal of Otolaryngology 2022;43:103371. [DOI: 10.1016/j.amjoto.2021.103371] [Reference Citation Analysis]
24 Sahu ES, Sahu A, Ghodgaonkar P, Lahoti K, Bhargava A. COVID-19-associated rhino-orbital- cerebral mixed mycoses with intracranial fungal granuloma - An aggressively managed rare entity. Indian J Ophthalmol 2021;69:2537-9. [PMID: 34427263 DOI: 10.4103/ijo.IJO_1598_21] [Reference Citation Analysis]
25 Fernández-García O, Guerrero-Torres L, Roman-Montes CM, Rangel-Cordero A, Martínez-Gamboa A, Ponce-de-Leon A, Gonzalez-Lara MF. Isolation of Rhizopus microsporus and Lichtheimia corymbifera from tracheal aspirates of two immunocompetent critically ill patients with COVID-19. Med Mycol Case Rep 2021;33:32-7. [PMID: 34307008 DOI: 10.1016/j.mmcr.2021.07.001] [Reference Citation Analysis]
26 John KJ, Nayar J, Mishra AK, Selvaraj V, Khan MS, Lal A. In-hospital clinical complications of COVID-19: a brief overview. Future Virol 2021. [PMID: 34777553 DOI: 10.2217/fvl-2021-0200] [Reference Citation Analysis]
27 Guzmán-Castro S, Chora-Hernandez LD, Trujillo-Alonso G, Calvo-Villalobos I, Sanchez-Rangel A, Ferrer-Alpuin E, Ruiz-Jimenez M, Corzo-Leon DE. COVID-19-associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico. Mycoses 2022;65:65-70. [PMID: 34674319 DOI: 10.1111/myc.13383] [Reference Citation Analysis]
28 Casalini G, Giacomelli A, Ridolfo A, Gervasoni C, Antinori S. Invasive Fungal Infections Complicating COVID-19: A Narrative Review. J Fungi (Basel) 2021;7:921. [PMID: 34829210 DOI: 10.3390/jof7110921] [Reference Citation Analysis]
29 Meshram HS, Kute VB, Chauhan S, Dave R, Patel H, Banerjee S, Desai S, Kumar D, Navadiya V, Mishra V. Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India. Int Urol Nephrol 2021. [PMID: 34792722 DOI: 10.1007/s11255-021-03057-5] [Reference Citation Analysis]
30 Muthu V, Rudramurthy SM, Chakrabarti A, Agarwal R. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World. Mycopathologia 2021. [PMID: 34414555 DOI: 10.1007/s11046-021-00584-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Patel DD, Adke S, Badhe PV, Lamture S, Marfatia H, Mhatre P. COVID-19 associated Rhino-Orbito-Cerebral Mucormycosis: Imaging spectrum and Clinico-radiological correlation- a single Centre experience. Clin Imaging 2021;82:172-8. [PMID: 34864270 DOI: 10.1016/j.clinimag.2021.10.014] [Reference Citation Analysis]
32 Bretagne S, Sitbon K, Botterel F, Dellière S, Letscher-Bru V, Chouaki T, Bellanger AP, Bonnal C, Fekkar A, Persat F, Costa D, Bourgeois N, Dalle F, Lussac-Sorton F, Paugam A, Cassaing S, Hasseine L, Huguenin A, Guennouni N, Mazars E, Le Gal S, Sasso M, Brun S, Cadot L, Cassagne C, Cateau E, Gangneux JP, Moniot M, Roux AL, Tournus C, Desbois-Nogard N, Le Coustumier A, Moquet O, Alanio A, Dromer F; French Mycoses Study Group. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave. Microbiol Spectr 2021;9:e0113821. [PMID: 34668768 DOI: 10.1128/Spectrum.01138-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Arora S, Hemmige VS, Mandke C, Chansoria M, Rawat SK, Dravid A, Sethi Y, Medikeri G, Jariwala SP, Puius YA; Mycotic Infections in COVID-19 (MUNCO) Network. Online Registry of COVID-19-Associated Mucormycosis Cases, India, 2021. Emerg Infect Dis 2021;27:2963-5. [PMID: 34586056 DOI: 10.3201/eid2711.211322] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]